To buy shares in Ironwood Pharmaceuticals Inc. Class A you will need a US based stock trading platform like Interactive Brokers or Moomoo where it currently costs $3.9 to buy one share in Ironwood Pharmaceuticals Inc. Class A (as of 16:00 01-Apr-2026). Which is a change of $0.39 or 11.11% from the last closing price of $3.51.
How To Buy Ironwood Pharmaceuticals Inc. Class A Stock
It may seem complicated to buy stock for the first time, but it’s actually very easy. Follow these simple steps to buy shares in Ironwood Pharmaceuticals Inc. Class A:
- Pick a stock broker (jump down to compare the best brokers for buying Ironwood Pharmaceuticals Inc. Class A stock)
- Deposit funds (bank transfer, ACH, wire transfer, or card)
- Search for the stock symbol: (NASDAQ:IRWD)
- Choose the number of shares you want to buy (1 share currently costs $3.9)
- Click buy (you can either trade immediately at “market” or set a “limit” to buy the stock cheaper if you think the price will go down)
- Track the performance of your Ironwood Pharmaceuticals Inc. Class A stock in your account (this will show your profit and loss)
- Ironwood Pharmaceuticals Inc. Class A is currently worth $635,927,385 based on the last closing price of $3.51 with 2,677,012 shares traded.
- The most recent Ironwood Pharmaceuticals Inc. Class A daily high has been $3.93 and daily low $3.56.
- The Ironwood Pharmaceuticals Inc. Class A stock price 52 week high has been $5.78 and the 52 week low $0.53.
Compare Brokers For Buying Ironwood Pharmaceuticals Inc. Class A Stock
Is Now A Good Time To Buy Ironwood Pharmaceuticals Inc. Class A Stock?
- Ironwood Pharmaceuticals Inc. Class A’s EPS (earnings per share) are 0.15. A high EPS indicates strong profitability but may already be priced in, while a low EPS could signal weak earnings or a turnaround opportunity, requiring industry comparison.
- Ironwood Pharmaceuticals Inc. Class A’s PE (price earnings ratio) is 26.47. A low PE ratio may suggest undervaluation but could also indicate slow growth or risk, whereas a high PE ratio reflects high growth expectations but may signal overvaluation, necessitating a check on earnings sustainability.
The below Ironwood Pharmaceuticals Inc. Class A share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold. Subscribe to Good Money Guide Analysis for expert opinion on the latest investment opportunities.